10,000 patients to test if platelet-rich plasma truly relieves arthritis and tendon pain.

NCT ID NCT07231471

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 10,000 adults with common joint or tendon problems—like knee arthritis, tennis elbow, or plantar fasciitis—who choose to receive a platelet-rich plasma (PRP) injection. PRP is made from a patient's own blood, spun to concentrate healing factors. Participants will report their pain and function over one year to see if the treatment helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP) injection
What this could lead to
If successful, this study could show that PRP injections provide meaningful pain relief and improved function for common joint and tendon conditions.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by natural recovery or placebo effects. PRP is not yet proven to be better than standard treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELBOW OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Utah Orthoaedic Center

    RECRUITING

    Salt Lake City, Utah, 84111-1334, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.